A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 10,600 shares of CLGN stock, worth $36,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,600
Holding current value
$36,782
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$3.25 - $4.92 $34,450 - $52,152
10,600 New
10,600 $38,000
Q4 2021

Feb 11, 2022

SELL
$12.0 - $22.48 $120,012 - $224,822
-10,001 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$16.0 - $21.75 $160,016 - $217,521
10,001 New
10,001 $169,000

Others Institutions Holding CLGN

About CollPlant Biotechnologies Ltd


  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $38.5M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.